Table 1.
Treatment group | ||||||
---|---|---|---|---|---|---|
Dose | Chorion | 24 hpf Survival | 24 hpf Tail flicks | 120 hpf Survival | 120 hpf Spinal curvature | 120 hpf Orientation/swim bladdera |
Control | + | 24 | 21 | 24 | 24 | 22 |
Control | – | 24 | 21 | 24 | 24 | 21 |
0.6 ppm | + | 22 | 20 | 22 | 22 | 22 |
0.6 ppm | – | 22 | 22 | 22 | 22 | 21 |
1.0 ppm | + | 22 | 19 | 22 | 22 | 18 |
1.0 ppm | – | 22 | 21 | 22 | 22 | 21 |
2.0 ppm | + | 22 | 21 | 22 | 22 | 19 |
2.0 ppm | – | 22 | 21 | 22 | 22 | 13 |
3.0 ppm | + | 22 | 21 | 22 | 22 | 7 |
3.0 ppm | – | 22 | 21 | 22 | 22 | 8 |
4.0 ppm | + | 22 | 21 | 22 | 22 | 2 |
4.0 ppm | – | 22 | 21 | 22 | 22 | 1 |
Sample sizes in this group vary greatly because of the inability to asses swim bladder inflation/embryo orientation in dead embryos.